DAIC

APRIL 11, 2024

TAVR and SAVR are procedures to replace a damaged aortic valve that is not functioning properly. TAVR and SAVR are procedures to replace a damaged aortic valve that is not functioning properly. The DEDICATE-DZHK6 trial compared TAVR vs. SAVR in 1,414 patients who underwent valve replacement procedures at 38 centers in Germany.

TAVR 111

TAVR Aortic valve Aortic COVID-19 111

DAIC

JUNE 3, 2024

Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported it has reached a significant milestone of performing over 5,000 transcatheter aortic valve replacement (TAVR) procedures, the first in New Jersey and among the first to accomplish this in the United States.

TAVR 105

TAVR Aortic valve Aortic Hospital 105

Frontiers in Cardiovascular Medicine

MARCH 9, 2025

Transcatheter aortic valve replacement (TAVR) has become a leading treatment for aortic stenosis, but managing thromboembolic and bleeding risks post-procedure remains challenging. This review examines current evidence on antithrombotic therapy after TAVR.

Aortic valve 52

Aortic valve Aortic TAVR Thrombosis 52

DAIC

MAY 15, 2024

Getty Images milla1cf Wed, 05/15/2024 - 19:10 May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart— transcatheter aortic valve replacement (TAVR)—and surgical aortic valve replacement (SAVR). 1.11, p=0.70) with similar long-term mortality risks.

Aortic valve 105

Aortic valve TAVR Outcomes Aortic 105

Frontiers in Cardiovascular Medicine

MARCH 20, 2025

ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., Procedural, in-hospital, and follow-up clinical outcomes were evaluated after procedures.ResultsThe average age of the 130 patients was 71.24.4

Aortic valve 52

Aortic valve Aortic Bicuspid/Mitral Stenosis 52

Open Heart

FEBRUARY 27, 2024

Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer. vs 74.7%, p=0.50).

Aortic valve 98

Aortic valve Cancer Aortic TAVR 98

American College of Cardiology

MARCH 6, 2024

What are the hemodynamic and clinical outcomes after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis (AS) and a small aortic annulus?

TAVR 60

TAVR Aortic Stenosis Aortic valve 60

CardiacWire

JANUARY 31, 2024

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The post SAVR’s Value in the TAVR Era appeared first on Cardiac Wire.

TAVR 69

TAVR Aortic valve Bicuspid/Mitral Aortic 69

Heart BMJ

JULY 10, 2024

Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR).

Aortic valve 98

Aortic valve Aortic Quality of Life TAVR 98

American College of Cardiology

JUNE 18, 2024

In this week's View, Dr. Eagle looks at secular trends of incidence and outcomes in severe aortic stenosis. He then examines titration of medications after acute heart failure.

Heart Failure 58

Heart Failure Stenosis Aortic TAVR 58

American College of Cardiology

FEBRUARY 18, 2025

The EARLY TAVR trial results demonstrate that early transcatheter aortic valve implantation in patients with asymptomatic severe aortic stenosis is superior to clinical surveillance in significantly reducing the composite primary outcome of death, stroke, or unplanned hospitalization for cardiovascular causes.

Stenosis 61

Stenosis Aortic Aortic valve TAVR 61

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

This concept should be applied when managing older patients with severe aortic stenosis. Although left ventricular wall hypertrophy is expected in patients with aortic stenosis, it should not be assumed that this is caused only by aortic stenosis.

Stenosis 69

Stenosis Aortic TAVR Aortic valve 69

American College of Cardiology

OCTOBER 28, 2024

Two separate late-breaking clinical trials – EARLY TAVR and EVOLVED – presented at TCT 2024 explore whether early aortic valve intervention improves outcomes in patients with asymptomatic aortic stenosis (AS).

TAVR 53

TAVR Aortic valve Aortic Stenosis 53

Cardiology Update

NOVEMBER 26, 2023

In light of the growing number of patients undergoing transcatheter aortic valve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. vs. 3.5%, p=0.80) between the redo-TAVR and native-TAVR populations.

TAVR 52

TAVR Aortic valve Outcomes Aortic 52

DAIC

MAY 1, 2024

We believe the tools, resources, and information shared at the meeting will provide the healthcare community with greater expertise to improve patient outcomes and also connect with their interventional cardiology colleagues,” said SCAI President George D. About 276,000 patients have undergone a TAVR procedure in the United States.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

DAIC

MARCH 12, 2024

milla1cf Tue, 03/12/2024 - 16:48 March 12, 2024 — Medtronic plc , a global leader in healthcare technology, today announced two late-breaking data presentations on four-year outcomes from the Evolut Low Risk Trial. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients from a U.S.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

American College of Cardiology

NOVEMBER 5, 2024

Patients younger than 65 years who received balloon-expandable valve TAVR for severe aortic stenosis during the low-surgical risk era were more likely to have comorbidities and exhibited higher rates of death and readmission at one year vs. patients aged 65 to 80 years, according to a study presented at TCT 2024 and simultaneously published in JAMA (..)

TAVR 45

TAVR Stenosis Aortic Outcomes 45

Circulation: Cardiovascular Interventions

MARCH 26, 2025

BACKGROUND:Current guidelines recommend surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and unfavorable iliofemoral access. Transcarotid transcatheter aortic valve replacement (TC-TAVR) has emerged as an alternative access in suboptimal transfemoral candidates, but no data exist comparing TC-TAVR and SAVR.

Aortic valve 40

Aortic valve Aortic Stenosis TAVR 40

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. 23), which was not associated with better/worse clinical outcomes in patients with prior CABG.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

Background Coronary artery disease (CAD) is a common finding in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Methods and results We retrospectively reviewed 1,487 consecutive TAVR cases performed at a single tertiary care medical center.

Aortic valve 64

Aortic valve Aortic TAVR Coronary Artery Disease 64

American College of Cardiology

NOVEMBER 13, 2024

What are clinical outcomes among patients with severe aortic stenosis (AS) and coronary artery disease (CAD) undergoing surgical aortic valve replacement (SAVR) plus revascularization versus transcatheter aortic valve replacement (TAVR) plus percutaneous coronary intervention (PCI)?

Aortic valve 60

Aortic valve Coronary Artery Disease TAVR Aortic 60

Open Heart

MAY 12, 2023

Objective To evaluate whether transcatheter or surgical aortic valve replacement (TAVR or SAVR) affects clinical and haemodynamic outcomes in symptomatic patients with moderately-severe aortic stenosis (AS). Clinical outcomes were reported through 2 years. Valve haemodynamics improved following TAVR (AVA 2.5±0.7

Aortic valve 52

Aortic valve Aortic Stenosis TAVR 52

Open Heart

JANUARY 31, 2022

Objectives To understand the patient and hospital level drivers of the variation in surgical versus trascatheter aortic valve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

Medical Xpress - Cardiology

MAY 15, 2024

A new study demonstrates parity between a minimally invasive procedure to replace the aortic valve in the heart—transcatheter aortic valve replacement (TAVR)—and surgical aortic valve replacement (SAVR).

Aortic valve 45

Aortic valve Aortic TAVR Stenosis 45

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels.

Aortic valve 64

Aortic valve Cardiac Rehabilitation Aortic TAVR 64

Open Heart

JUNE 21, 2022

Background Increase in left ventricular filling pressure (FP) and diastolic dysfunction are established consequences of progressive aortic stenosis (AS). However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear.

Aortic valve 52

Aortic valve TAVR Aortic AFIB 52

Society of Thoracic Surgeons - Congenital

JANUARY 24, 2025

At STS 2025, Dr. Tomaz Mesar presented a study comparing outcomes of TAVR and SAVR in low-risk patients with aortic stenosis.

Aortic valve 52

Aortic valve Aortic TAVR Stenosis 52

American College of Cardiology

FEBRUARY 12, 2024

The goal of the NOTION trial was to compare outcomes after transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in unselected patients with severe degenerative aortic stenosis.

Aortic valve 56

Aortic valve Aortic TAVR Stenosis 56

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 13, 2023

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. The primary outcome was a composite of all-cause mortality or hospital readmission within 1 year. Below 5000 steps, the adjusted hazard ratio of composite outcome associated with each 1000-step count increase was 0.67 (0.50–0.89;P=0.007). years; 61% women).

TAVR 40

TAVR Aortic valve Aortic Outcomes 40

Circulation

OCTOBER 25, 2023

Background:The optimal treatment in patients with severe aortic stenosis (AS) and small aortic annulus (SAA) remains to be determined. Participants were 151 patients with severe AS and SAA (mean diameter <23 mm) were randomized (1:1) to TAVR (n=77) vs SAVR (n=74), The primary outcome was impaired valve hemodynamics (i.e.

Aortic valve 40

Aortic valve Aortic TAVR Stenosis 40

Frontiers in Cardiovascular Medicine

APRIL 7, 2024

Transcatheter aortic valve replacement (TAVR) has increasingly become a safe, feasible, and widely accepted alternative surgical treatment for patients with severe symptomatic aortic stenosis.

Aortic valve 52

Aortic valve Aortic TAVR Risk Factors 52

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Primary outcome was all-cause mortality. Exposure of interest was PVD. 2VB-PVD, HR 1.12; 95% CI, 1.09-1.15, 1.15, and 3VB-PVD, HR 1.31; 95% CI, 1.26-1.36).

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Journal of the American Heart Association

FEBRUARY 26, 2025

BackgroundCardiac fibrosis is common in patients with severe aortic stenosis and an independent predictor of death. ConclusionsCirculating TIMP1 is an independent predictor of reduced 2year overall survival in patients undergoing TAVR. 95% CI, 2.69.7];P<0.001) P<0.001) and multivariable (adjusted hazard ratio, 2.2 [95%

Aortic valve 45

Aortic valve Aortic TAVR Biomarkers 45

European Journal of Heart Failure

JANUARY 31, 2024

TAVR in heart failure. ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The prognostic covariates and optimal timing of TAVR in patients with less than severe AS remain unclear.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV. to 4.58, p=0.04). to 4.58, p=0.04).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Conversely, TAVR-explant can be offered to most patients who are surgical candidates, but the reported outcomes have shown high mortality and morbidity.

Aortic valve 40

Aortic valve Aortic TAVR Heart Valves 40

European Journal of Heart Failure

FEBRUARY 26, 2025

We propose management pathways to optimize HFrEF treatment in the context of low BP, ultimately aiming to improve patient outcomes. Proposed approach for clinical management and therapeutic optimization in patients with heart failure with reduced ejection fraction and low blood pressure.

Blood Pressure 58

Blood Pressure Heart Failure Aortic valve TAVR 58